Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2006 by National Cancer Institute (NCI).
Recruitment status was  Active, not recruiting
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: November 9, 2004
Last updated: November 12, 2008
Last verified: January 2006